SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Robert A. Smith, Deana Manassaram-Baptiste, Durado Brooks, Mary Doroshenk, Stacey Fedewa, Debbie Saslow, Otis W. Brawley, Richard Wender, Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening, CA: A Cancer Journal for Clinicians, 2015, 65, 1
  2. 2
    Heather Orom, Willie Underwood, D. Lynn Homish, Marc T. Kiviniemi, Gregory G. Homish, Christian J. Nelson, Zvi Schiffman, Prostate cancer survivors' beliefs about screening and treatment decision-making experiences in an era of controversy, Psycho-Oncology, 2015, 24, 2
  3. 3
    Jaquelyn L. Jahn, Edward L. Giovannucci, Meir J. Stampfer, The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era, International Journal of Cancer, 2015, 136, 7
  4. 4
    Marco Randazzo, Josef Beatrice, Andreas Huber, Rainer Grobholz, Lukas Manka, Felix K. Chun, Franz Recker, Maciej Kwiatkowski, A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening, European Urology, 2014,

    CrossRef

  5. 5
    Igor Brikun, Deborah Nusskern, Daniel Gillen, Amy Lynn, Daniel Murtagh, John Feczko, William G Nelson, Diha Freije, A panel of DNA methylation markers reveals extensive methylation in histologically benign prostate biopsy cores from cancer patients, Biomarker Research, 2014, 2, 1

    CrossRef

  6. You have free access to this content6
    Ted A. Skolarus, Andrew M.D. Wolf, Nicole L. Erb, Durado D. Brooks, Brian M. Rivers, Willie Underwood, Andrew L. Salner, Michael J. Zelefsky, Jeanny B. Aragon-Ching, Susan F. Slovin, Daniela A. Wittmann, Michael A. Hoyt, Victoria J. Sinibaldi, Gerald Chodak, Mandi L. Pratt-Chapman, Rebecca L. Cowens-Alvarado, American Cancer Society prostate cancer survivorship care guidelines, CA: A Cancer Journal for Clinicians, 2014, 64, 4
  7. 7
    Gregory B. Auffenberg, Joshua J. Meeks, Application of the 2013 American Urological Association early detection of prostate cancer guideline: Who will we miss?, World Journal of Urology, 2014, 32, 4, 959

    CrossRef

  8. 8
    William Gorday, Hossein Sadrzadeh, Lawrence de Koning, Christopher Naugler, Association of sociodemographic factors and prostate-specific antigen (PSA) testing, Clinical Biochemistry, 2014, 47, 16-17, 164

    CrossRef

  9. You have free access to this content9
    Robert A. Smith, Deana Manassaram-Baptiste, Durado Brooks, Vilma Cokkinides, Mary Doroshenk, Debbie Saslow, Richard C. Wender, Otis W. Brawley, Cancer screening in the United States, 2014: A review of current American Cancer Society guidelines and current issues in cancer screening, CA: A Cancer Journal for Clinicians, 2014, 64, 1
  10. 10
    T. A. Wallace, R. F. Downey, C. J. Seufert, A. Schetter, T. H. Dorsey, C. A. Johnson, R. Goldman, C. A. Loffredo, P. Yan, F. J. Sullivan, F. J. Giles, F. Wang-Johanning, S. Ambs, S. A. Glynn, Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokers, Carcinogenesis, 2014, 35, 9, 2074

    CrossRef

  11. 11
    Matthew J. Maurice, Robert Abouassaly, Patient Opinions on Prostate Cancer Screening Are Swayed by the United States Preventative Services Task Force Recommendations, Urology, 2014, 84, 2, 295

    CrossRef

  12. 12
    Andreas Scorilas, Konstantinos Mavridis, Predictions for the future of kallikrein-related peptidases in molecular diagnostics, Expert Review of Molecular Diagnostics, 2014, 14, 6, 713

    CrossRef

  13. 13
    Prokar Dasgupta, Quality has no boundaries, BJU International, 2014, 113, 1
  14. 14
    Prokar Dasgupta, Valentine's Day PSA, BJU International, 2014, 113, 2
  15. 15
    John W. Davis, Urological oncology in the BJUI, BJU International, 2013, 112, 5